Nintedanib Inhibits Fibroblast Activation and Ameliorates Fibrosis in Preclinical Models of Systemic Sclerosis
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2014-207109
Full Text
Open PDFAbstract
Available in full text
Date
April 9, 2015
Authors
Publisher
BMJ